Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression
Current Medical Research and Opinion · 2024
DOI: 10.1080/03007995.2024.2425387 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Current Medical Research and Opinion, 2024. Verfasst von Francesco Pesce und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ospedale Fatebenefratelli Isola Tiberina - Gemelli Isola, Rome, Italy. Hauptthemen laut MEDLINE: Lupus Nephritis, Disease Progression, Kidney Function Tests. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Otsuka Pharmaceutical Development & Commercialization, Inc..
Abstract (Originalsprache)
OBJECTIVE: Patients with lupus nephritis (LN), a severe renal manifestation of systemic lupus erythematosus, should be monitored for progression of chronic kidney disease to end-stage renal disease but data on renal function testing in LN patients are limited. This real-world analysis aimed to evaluate nephrologists' use of renal function tests to support LN diagnosis and monitoring and to examine the impact of disease progression in LN patients in Europe. METHODS: Data were drawn from the Adelphi Lupus Disease Specific Programme, a cross-sectional survey of nephrologists and their next five consulting patients with LN in France, Germany, Italy, Spain, and the United Kingdom in 2021. Nephrologists provided demographic and clinical information for each patient and the same patients completed a self-reported questionnaire. Using a checkbox, patients provided informed consent to take part in the survey. RESULTS: Nephrologists (n = 72) provided data on 376 patients with LN. Estimated glomerular filtration rate (eGFR) or proteinuria testing was not undertaken in around 10% and 50% of these patients, respectively. Regression analysis predicted reduction in renal function (disease progression) following LN diagnosis whilst bivariate analyses showed significantly worse outcomes for patients with progressed disease: worse pain, fatigue, treatment satisfaction, and patient-reported health state and activity impairment. CONCLUSION: Our study revealed lower-than-expected nephrologist-reported use of renal function testing to support diagnosis/monitoring of patients with LN in real-world clinical settings in Europe. Lower quality of life (QoL) was observed in patients with more progressed disease. Increased use of renal function testing is needed so that all LN patients are monitored closely to manage disease progression and avoid the associated QoL impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ospedale Fatebenefratelli Isola Tiberina - Gemelli Isola, Rome, Italy.
- Otsuka Pharmaceutical Development & Commercialization Inc., Rockville, MD, USA.
- Otsuka Pharmaceutical Europe Ltd., Wexham, UK.
- Adelphi Real World, Bollington, UK.
- Otsuka Pharma GmbH, Frankfurt am Main, Germany.
ORCID-Profile: Francesco Pesce, Emily Goddard, Liane Gillespie-Akar
Förderung
- Otsuka Pharmaceutical Development & Commercialization, Inc.
Zitieren
APA
Pesce, F., Fernandes, A., Clamp, D., Asin, B., Goddard, E., Gillespie-Akar, L., & Eberhardt, A. (2024). Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2024.2425387
Vancouver
Pesce F, Fernandes A, Clamp D, Asin B, Goddard E, Gillespie-Akar L, et al. Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression. Current Medical Research and Opinion. 2024. doi:10.1080/03007995.2024.2425387
BibTeX
@article{Pesce2024,
author = {Pesce, Francesco and Fernandes, Ancilla and Clamp, David and Asin, Beatriz and Goddard, Emily and Gillespie-Akar, Liane and Eberhardt, Alice},
title = {Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression},
journal = {Current Medical Research and Opinion},
year = {2024},
doi = {10.1080/03007995.2024.2425387}
}
EUVIMED